Menu menu
  • Flux RSS
  • Twitter
  • Facebook
  • Google Plus
  • LinkedIn
Newsletter - June 2016

Newsletter - June 2016

Another Busy Month at Genopole as we ease (...)

Consult our latest key figures for 2015

Consult our latest key figures for 2015

Year 2015 marked the history of the biocluster in

Synthetic Biology: From Ideas to Market

Synthetic Biology: From Ideas to Market

Synthetic biology stands among the major (...)

Genopole's Business Support

Genopole’s Business Support

The leading biotech and biotherapy cluster

The leading biotech and biotherapy cluster

Synthetic and systems biology

Synthetic and systems biology

Our real estate offer

Our real estate offer

A medical environment

A medical environment

Agenda

13.10

B·Debate : Beyond Cancer Genomes

Conference on Epigenetics and Cancer Over the past few years, the genomes and transcriptomes of thousands of tumors have been sequenced. This information has revealed an enormous diversity of (...)

Read more

08.09

BIOREGATE. European Regenerative Medicine Forum

Bioregate Forum is a great opportunity to present and discuss your company’s or organisation’s latest achievements in research, innovation, clinical trials or market access approaches. The (...)

Read more

27.06

WIN 2016 Symposium

“Innovative Approaches to Improve Cancer Patient Outcomes” It is the 8th edition of a successful series of symposia organized by the Worldwide Innovative Networking (WIN) Consortium, dedicated to (...)

Read more

Live news

  • Genopole

    25 July 2016

    RT @AFEcreation: #Sénat : la Délégation aux entreprises dresse le bilan de son année à l’écoute des entrepreneurs sur le terrain https://t.…

  • Genopole

    25 July 2016

    RT @le_Parisien: Maladie de Lyme : l'épidémie cachée https://t.co/rGVKuxXJKF

  • Genopole

    25 July 2016

    RT @AlsaceBiovalley: #startup derniers jours pour exposez vos compétences au 118e Congrès Français de #Chirurgie Deadline 27/07: https://t.…

  • Genopole

    25 July 2016

    RT @GlobalBioenergi: #GlobalBioenergies $ALGBE Partenariat avec ASPEN (Suède) sur bio #isooctane pour carburants spéciaux https://t.co/3or…

  • Genopole

    25 July 2016

    #SYNBIO2016 - seminar - Synthetic Biology: From Ideas to Market - https://t.co/9suJuP5WPN #synbio https://t.co/ZMWZ0rSKHv

  • Genopole

    25 July 2016

    Beyond Cancer Genomes. Barcelona Conference on Epigenetics and Cancer Thursday, 13 Oct 2016 09:00 https://t.co/Ylo871q87O

  • Genopole

    25 July 2016

    #agenda 15-17/09 #FV2016 #biotech, #bioéconomie face aux mutations des territoires https://t.co/v7ZFMTFcnw https://t.co/vEkBUWgEyc

  • Genopole

    25 July 2016

    @MATWIN_Bdx et cancer-campus : 1 atelier pour les créateurs d‘#entreprises innovantes en oncologie https://t.co/UUR9meXq4x

  • Genopole

    25 July 2016

    Pour participer à un projet européen comme #EUREKA RDV le 20/09 INFODAY #H2020 @EU_H2020 https://t.co/VVS9drIoAy https://t.co/P9STFOdEy4

  • Genopole

    25 July 2016

    Que peut-on attendre de la génétique du futur ? https://t.co/SizmwGzMWH via @Sciences_Avenir

  • Genopole

    24 July 2016

    RT @Labiotech_eu: #Infographic: What are the key challenges in Personalized Medicine? @geneticinsidER https://t.co/S78i0WtuxN https://t.co/…

  • Genopole

    23 July 2016

    Voyage au cœur des cellules https://t.co/RNZXvJ9pIJ

  • Global Bioenergies on track with the development schedule of its bio-isobutene production process

    Global Bioenergies, an industrial biology company developing sustainable routes to light olefins, announces significant progress in the development of its process for the production of biological (...)

  • Gene Signal and collaborators demonstrate successful activity of topical aganirsen

    Gene Signal announced the publication of data demonstrating the significant activity of aganirsen (GS-101, eye drop) in two important models of retinal neovascular disease, wet age-related (...)

Sharing expertise, competencies and means

Sharing expertise, competencie

Sharing expertise, competencies and means

The Infrastructures and Platforms Department (...)


Create, Develop, Attract

Create, Develop, Attract

Create, Develop, Attract

The mission of the Genopole Enterprises team (...)